Assessing the feasibility of neonatal chest MRI for bronchopulmonary dysplasia using a standard 1.5-Tesla scanner.

Jantine J Wisse^1,2, Bernadette B L J Elders^3,4, Merlijn Bonte³, Piotr A Wielopolski⁴, André A Kroon¹, Harm A W M Tiddens^3,5, Liesbeth Duijts^1,3, Mariëlle W H Pijnenburg³, Irwin K M Reiss^1,6, Pierluigi Ciet^7,8

¹Division of Neonatology, Department of Neonatal and Pediatric Intensive Care, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

²Department of Adult Intensive Care, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

³Division of Respiratory Medicine and Allergology, Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

⁴Department of Radiology and Nuclear Medicine, Erasmus Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands.

⁵Thirona B.V, Nijmegen, The Netherlands.

⁶Medical University Eppendorf, Medical Children's Hospital, Divison of Neonatology and Pediatric Intensive Care, Hamburg, Germany.

⁷Department of Radiology and Nuclear Medicine, Erasmus Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands. p.ciet@erasmusmc.nl.

⁸Department of Radiology, Policlinic University Hospital, Cagliari, Italy. p.ciet@erasmusmc.nl.

PubMed PMC DOI PDF

Abstract

OBJECTIVE: Accurate imaging is essential for assessing structural lung abnormalities in children with bronchopulmonary dysplasia (BPD). Chest MRI offers a radiation-free alternative to CT and enables silent scanning. This study aimed to develop and evaluate a chest MRI protocol for BPD using a standard 1.5-Tesla (T) MRI scanner with a dedicated neonatal chest coil. MATERIALS AND METHODS: In this…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.